Neutropenia possibly caused by cefoperazone/sulbactam
Neutropenia is a rare complication of drug therapy and is usually underdiagnosed. Cefoperazone/sulbactam is a combination of broad-spectrum antibacterial agents. Data on cefoperazone/sulbactam-induced neutropenia are limited. Herein, we report the case of a 35 year-old female patient who was admitted to the hospital due to an appendiceal abscess. After anti-infective treatment with cefoperazone/sulbactam, the patient developed neutropenia on day 4. After discontinuing treatment with cefoperazone/sulbactam, the patient's white blood cells and neutrophils gradually returned to normal. Hence, clinicians should monitor changes in neutrophil count during cefoperazone/sulbactam therapy and provide timely treatment.
Authors
- Yun Li
- Xinglin He
- Ran Wang (ORCID: https://orcid.org/0009-0005-2364-8920)
Institutions
- Lishui City People's Hospital (CN)
Publication Details
- Journal
- European Journal of Hospital Pharmacy
- Published
- 2024-10-17
- DOI
- https://doi.org/10.1136/ejhpharm-2024-004188
- Primary Topic
- Blood disorders and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00